Design, synthesis and antimicrobial activities of some new quinoline derivatives carrying 1,2,3-triazole moiety

dc.contributor.authorThomas, K.D.
dc.contributor.authorVasudeva Adhikari, A.V.
dc.contributor.authorShetty, N.S.
dc.date.accessioned2026-02-05T09:36:14Z
dc.date.issued2010
dc.description.abstractA new series of [1-(6-methoxy-2-methylquinolin-4-yl)-1H-1,2,3-triazol-4-yl] methanamine derivatives were synthesized starting from 4-methoxyaniline through multi-step reactions. The title compounds 5a-y were prepared by treating the azide intermediate 4 with propargyl bromide and different alkyl/heterocyclic amines in a sequential three component synthesis. All the new compounds were characterized by spectral and elemental analyses. The newly synthesized final compounds were evaluated for their in vitro antibacterial and antifungal activities against pathogenic strains. The preliminary screening results indicated that most of the compounds demonstrated moderate to very good antibacterial and antifungal activities, comparable to the first-line drugs. Twenty five new derivatives of [1-(6-methoxy-2-methylquinolin-4-yl)-1H-1,2,3- triazol-4-yl] methanamine have been synthesized and the most effective compounds have MIC of 6.25 ?g/mL, which are in comparable with present antibiotics. © 2010 Elsevier Masson SAS. All rights reserved.
dc.identifier.citationEuropean Journal of Medicinal Chemistry, 2010, 45, 9, pp. 3803-3810
dc.identifier.issn2235234
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2010.05.030
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/27422
dc.subject1 [1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl] n,n dimethyl methanamine
dc.subject1 [4 [[1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl]methyl]piperazin 1 yl]ethanone
dc.subject4 [4 [(4 cyclohexylpiperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl] 6 methoxy 2 methylquinoline
dc.subject4 [4 [(4 ethylpiperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl] 6 methoxy 2 methyl quinoline
dc.subject4 [4 [(4 ethylpiperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl] 6 methoxy 2 methylquinoline
dc.subject4 [4 [(4 isopropylpiperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl] 6 methoxy 2 methylquinoline
dc.subject4 [4 [[4 (2 fluorophenyl)piperazin 1 yl]methyl] (1h) 1,2,3 triazol 1 yl] 6 methoxy 2 methylquinoline
dc.subject4 [4 [[4 (4 fluorophenyl)piperazin 1 yl]methyl] (1h) 1,2,3 triazol 1 yl] 6 methoxy 2 methylquinoline
dc.subject6 methoxy 2 methyl 4 [4 [(4 methylpiperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl]quinoline
dc.subject6 methoxy 2 methyl 4 [4 [(4 morpholinopiperidin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl]quinoline
dc.subject6 methoxy 2 methyl 4 [4 [(4 p tolylpiperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl]quinoline
dc.subject6 methoxy 2 methyl 4 [4 [(4 phenylpiperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl]quinoline
dc.subject6 methoxy 2 methyl 4 [4 [(piperidin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl]quinoline
dc.subject6 methoxy 2 methyl 4 [4 [(pyrrolidin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl]quinoline
dc.subject6 methoxy 4 [4 [(4 (4 methoxyphenyl) piperazin 1 yl)methyl] (1h) 1,2,3 triazol 1 yl] 2 methylquinoline
dc.subject6 methoxy 4 [4 [[4 (4 methoxy 2 methylphenyl)piperazin 1 yl]methyl] (1h) 1,2,3 triazol 1 yl] 2 methylquinoline
dc.subjectciclopiroxolamine
dc.subjectciprofloxacin
dc.subjectn [1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl]methyl cyclopropanamine
dc.subjectn [1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl]methylamine
dc.subjectn [[1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl]methyl]butan 2 amine
dc.subjectn [[1 (6 methoxy 2 methylquinolin 4 yl) (1h) imidazol 4 yl]methyl]cyclohexanamine
dc.subjectn [[1 (6 methoxy 2 methylquinolin 4 yl) (1h) imidazol 4 yl]methyl]cyclopentanamine
dc.subjectn ethyl n [[1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl]methyl]ethanamine
dc.subjectn1 [[1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl]methyl] n1,n2,n2 trimethylethane 1,2 diamine
dc.subjectn1 [[1 (6 methoxy 2 methylquinolin 4 yl) (1h) 1,2,3 triazol 4 yl]methyl] n3,n3 diimethylpropane 1,3 diamine
dc.subjectquinoline derivative
dc.subjectunclassified drug
dc.subjectantifungal activity
dc.subjectantimicrobial activity
dc.subjectarticle
dc.subjectAspergillus flavus
dc.subjectAspergillus fumigatus
dc.subjectbacterial strain
dc.subjectbacterium culture
dc.subjectCandida albicans
dc.subjectcontrolled study
dc.subjectdrug design
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectEscherichia coli
dc.subjectfungal strain
dc.subjectinfrared spectroscopy
dc.subjectKlebsiella pneumoniae
dc.subjectminimum inhibitory concentration
dc.subjectnonhuman
dc.subjectnuclear magnetic resonance spectroscopy
dc.subjectPenicillium marneffei
dc.subjectPseudomonas aeruginosa
dc.subjectStaphylococcus aureus
dc.subjectStreptococcus pyogenes
dc.subjectTrichophyton mentagrophytes
dc.subjectAmines
dc.subjectAniline Compounds
dc.subjectAnti-Infective Agents
dc.subjectBacteria
dc.subjectDrug Design
dc.subjectFungi
dc.subjectMicrobial Sensitivity Tests
dc.subjectQuinolines
dc.subjectTriazoles
dc.titleDesign, synthesis and antimicrobial activities of some new quinoline derivatives carrying 1,2,3-triazole moiety

Files

Collections